GlassScriptPhysician profile
Alexis Platek
NPI 1013538784
$727.81
in general payments reported to CMS, 2019-2025
17 companies · $453 in 2025
The $453 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $275 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $93.58 | 2024-2025 | Slynd |
| Novo Nordisk INC | $88.13 | 2024-2025 | Wegovy |
| Daiichi Sankyo INC. | $76.24 | 2024 | Injectafer |
| Amgen INC. | $68.95 | 2024-2025 | Evenity, Prolia, Prolia |
| Biogen, INC. | $54.26 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $43.87 | 2025 | Myfembree |
| Astellas Pharma US INC | $43.32 | 2024 | Veozah |
| Dexcom, INC. | $42.95 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $42.05 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $39.73 | 2025 | Zepbound, Mounjaro |
| Mayne Pharma Commercial LLC | $30.98 | 2024-2025 | |
| Organon LLC | $22.28 | 2024 | |
| Hologic Sales and Service, LLC | $19.03 | 2024 | Aptima |
| Millicent US INC | $16.43 | 2025 | Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $15.77 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $15.25 | 2025 | |
| Pfizer INC. | $14.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Platek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.